118 related articles for article (PubMed ID: 22200442)
1. Dietary and synthetic activators of the antistress gene response in treatment of renal disease.
Thornalley PJ; Rabbani N
J Ren Nutr; 2012 Jan; 22(1):195-202. PubMed ID: 22200442
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
3. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
Itoh K; Mimura J; Yamamoto M
Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
[TBL] [Abstract][Full Text] [Related]
4. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
Saito H
Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
[TBL] [Abstract][Full Text] [Related]
5. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
Kim HJ; Vaziri ND
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.
Nakai K; Fujii H; Kono K; Goto S; Kitazawa R; Kitazawa S; Hirata M; Shinohara M; Fukagawa M; Nishi S
Am J Hypertens; 2014 Apr; 27(4):586-95. PubMed ID: 24025724
[TBL] [Abstract][Full Text] [Related]
7. Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease?
Pedruzzi LM; Stockler-Pinto MB; Leite M; Mafra D
Biochimie; 2012 Dec; 94(12):2461-6. PubMed ID: 22874821
[TBL] [Abstract][Full Text] [Related]
8. Control of oxidative stress by the Keap1-Nrf2 pathway.
Stewart JD; Hengstler JG; Bolt HM
Arch Toxicol; 2011 Apr; 85(4):239. PubMed ID: 21431330
[No Abstract] [Full Text] [Related]
9. Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila.
Sykiotis GP; Bohmann D
Dev Cell; 2008 Jan; 14(1):76-85. PubMed ID: 18194654
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
[TBL] [Abstract][Full Text] [Related]
11. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia.
Mann GE; Niehueser-Saran J; Watson A; Gao L; Ishii T; de Winter P; Siow RC
Sheng Li Xue Bao; 2007 Apr; 59(2):117-27. PubMed ID: 17437032
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
13. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
Soetikno V; Sari FR; Lakshmanan AP; Arumugam S; Harima M; Suzuki K; Kawachi H; Watanabe K
Mol Nutr Food Res; 2013 Sep; 57(9):1649-59. PubMed ID: 23174956
[TBL] [Abstract][Full Text] [Related]
14. Keap1-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles.
Turpaev KT
Biochemistry (Mosc); 2013 Feb; 78(2):111-26. PubMed ID: 23581983
[TBL] [Abstract][Full Text] [Related]
15. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?
Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D
J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of Keap1-Nrf2 signaling.
Guo Y; Yu S; Zhang C; Kong AN
Free Radic Biol Med; 2015 Nov; 88(Pt B):337-349. PubMed ID: 26117320
[TBL] [Abstract][Full Text] [Related]
17. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways.
Gan FF; Ling H; Ang X; Reddy SA; Lee SS; Yang H; Tan SH; Hayes JD; Chui WK; Chew EH
Toxicol Appl Pharmacol; 2013 Nov; 272(3):852-62. PubMed ID: 23899529
[TBL] [Abstract][Full Text] [Related]
18. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
Müller T; Hengstermann A
Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
[TBL] [Abstract][Full Text] [Related]
19. [Disease regulation by Nrf2 antioxidant system].
Itoh K
Seikagaku; 2009 Jun; 81(6):447-55. PubMed ID: 19618868
[No Abstract] [Full Text] [Related]
20. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
